Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > IPO

<< Previous

Bullboard Posts

Next >>

Comment by bringon10baggeron Mar 31, 2021 7:32pm

257 Views

Post# 32919821

RE:RE:RE:IPO

This hardly seems reasonable based on the Nuance deal, 100M overall for 10% of market share for Otena, prorating entire MS to be worth 1B, certainly seems on low side for potential sales of 4B annually and 21B by 2034, in just US, EU, and Japan......am I missing something here??

MrMugsy wrote:

JimmyJ wrote:

Marky1 wrote:
The original IPO was was June 18 th 2013....It began trading at the equivalent price of $5.50 (.55$ presplit). That's almost 8 years of no movement of the SP...Our long voyage is about to break out, IMHO.
The way I see things going...Further partnership deals with pharm companies such as GUD for Latin America, other deals for the USA, Europe, Japan and the rest of the world...Money swelling up our chest...
Final dissolution of ANTIBE Holding Corporation leading to one strong and uncomplicated entity.
By August, 7 months after hiring Dr. Haut, i believe that he will present to the world a huge acquisition deal with Bayer for the entire company. It took him exactly 7 months to ink a deal to sell the company that he was working for ( AskBio) for 4B$ USD
people..hang on to your shares...worth their weight in gold !

Exciting days are coming..

Correct me if I'm wrong, I don't believe Don Haut is leading the negotiations onbehalf of Antibe. Don was appointed to the Partnering Advisory Team, which is not a full time gig. My guess is the team meets with Dan and the ATE leadership team periodically to discuss strategy, open doors, set up connections etc. Not trying to burst your bubble here Marky, I like your enthusiasm. Negotiations are most likely being handled by ATE's leadership team, instead of Haut.

Does anyone have details on the partnering team? Are they all salaried, part time, how often do they meet, what skin do they have in the game, etc? I recall Dan saying in one of the March presentations that that team will become more involved in the months ahead.

You could be right JimmyJ ... might be a weekly meeting with Dan - but - I don't know the details of the team make-up.

Marky is excited about the $4B deal with AskBio and he's hoping Don has the right skills and connections to get us to the promised land.

A little too early to call the end game (if there is an end game) - but I'm sure they're working on potential partnering. I like the idea of being paid twice, before P3 and after P3 in a deal like AskBio ... think it could serve us well.

IMO